BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 25076238)

  • 1. Salvage stereotactic re-irradiation with CyberKnife for locally recurrent head and neck cancer: a single center experience.
    Bonomo P; Cipressi S; Iermano C; Bonucci I; Masi L; Doro R; Favuzza V; Paiar F; Simontacchi G; Meattini I; Greto D; Agresti B; Livi L; Biti G
    Tumori; 2014; 100(3):278-83. PubMed ID: 25076238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fractionated stereotactic radiotherapy as reirradiation for locally recurrent head and neck cancer.
    Roh KW; Jang JS; Kim MS; Sun DI; Kim BS; Jung SL; Kang JH; Yoo EJ; Yoon SC; Jang HS; Chung SM; Kim YS
    Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1348-55. PubMed ID: 19117695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvage reirradiaton with stereotactic body radiotherapy for locally recurrent head-and-neck tumors.
    Cengiz M; Özyiğit G; Yazici G; Doğan A; Yildiz F; Zorlu F; Gürkaynak M; Gullu IH; Hosal S; Akyol F
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):104-9. PubMed ID: 20675075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of nomogram-based prediction of survival probability after salvage re-irradiation of head and neck cancer.
    Shikama N; Kumazaki Y; Tsukamoto N; Ebara T; Makino S; Abe T; Nakahira M; Sugasawa M; Kato S
    Jpn J Clin Oncol; 2013 Feb; 43(2):154-60. PubMed ID: 23242582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage stereotactic reirradiation with or without cetuximab for locally recurrent head-and-neck cancer: a feasibility study.
    Comet B; Kramar A; Faivre-Pierret M; Dewas S; Coche-Dequeant B; Degardin M; Lefebvre JL; Lacornerie T; Lartigau EF
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):203-9. PubMed ID: 22331006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Second infield re-irradiation with a resulting cumulative equivalent dose (EQD2
    von der Grün J; Köhn J; Loutfi-Krauss B; Blanck O; Rödel C; Balermpas P
    Head Neck; 2019 Apr; 41(4):E48-E54. PubMed ID: 30521102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated stereotactic radiotherapy using CyberKnife as a boost treatment for head and neck cancer, a multi-institutional survey: impact of planning target volume.
    Yamazaki H; Ogita M; Himei K; Nakamura S; Yoshida K; Kotsuma T; Yamada Y; Fujiwara M; Baek S; Yoshioka Y
    Anticancer Res; 2014 Oct; 34(10):5755-9. PubMed ID: 25275085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensity-modulated radiotherapy for previously irradiated, recurrent head-and-neck cancer.
    Chen YJ; Kuo JV; Ramsinghani NS; Al-Ghazi MS
    Med Dosim; 2002; 27(2):171-6. PubMed ID: 12074469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of tumor volume and radiotherapy dose on outcome in previously irradiated recurrent squamous cell carcinoma of the head and neck treated with stereotactic body radiation therapy.
    Rwigema JC; Heron DE; Ferris RL; Andrade RS; Gibson MK; Yang Y; Ozhasoglu C; Argiris AE; Grandis JR; Burton SA
    Am J Clin Oncol; 2011 Aug; 34(4):372-9. PubMed ID: 20859194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fractionated stereotactic radiosurgery for reirradiation of head-and-neck cancer.
    Unger KR; Lominska CE; Deeken JF; Davidson BJ; Newkirk KA; Gagnon GJ; Hwang J; Slack RS; Noone AM; Harter KW
    Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1411-9. PubMed ID: 20056341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective phase 2 trial of reirradiation with stereotactic body radiation therapy plus cetuximab in patients with previously irradiated recurrent squamous cell carcinoma of the head and neck.
    Vargo JA; Ferris RL; Ohr J; Clump DA; Davis KS; Duvvuri U; Kim S; Johnson JT; Bauman JE; Gibson MK; Branstetter BF; Heron DE
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(3):480-8. PubMed ID: 25680594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fractionated stereotactic body radiation therapy in the treatment of previously-irradiated recurrent head and neck carcinoma: updated report of the University of Pittsburgh experience.
    Rwigema JC; Heron DE; Ferris RL; Gibson M; Quinn A; Yang Y; Ozhasoglu C; Burton S
    Am J Clin Oncol; 2010 Jun; 33(3):286-93. PubMed ID: 19875950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated in-field radiosurgery for locally recurrent brain metastases: Feasibility, results and survival in a heavily treated patient cohort.
    Balermpas P; Stera S; Müller von der Grün J; Loutfi-Krauss B; Forster MT; Wagner M; Keller C; Rödel C; Seifert V; Blanck O; Wolff R
    PLoS One; 2018; 13(6):e0198692. PubMed ID: 29874299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body re-irradiation therapy for locally recurrent prostate cancer after external-beam radiation therapy: Initial report.
    Janoray G; Reynaud-Bougnoux A; Ruffier-Loubière A; Bernadou G; Pointreau Y; Calais G
    Cancer Radiother; 2016 Jun; 20(4):275-81. PubMed ID: 27342944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salvage re-irradiation for recurrent head and neck cancer.
    Lee N; Chan K; Bekelman JE; Zhung J; Mechalakos J; Narayana A; Wolden S; Venkatraman ES; Pfister D; Kraus D; Shah J; Zelefsky MJ
    Int J Radiat Oncol Biol Phys; 2007 Jul; 68(3):731-40. PubMed ID: 17379449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyperfractionated stereotactic reirradiation for recurrent head and neck cancer.
    Cvek J; Knybel L; Skacelikova E; Stransky J; Matousek P; Zelenik K; Res O; Otahal B; Molenda L; Feltl D
    Strahlenther Onkol; 2016 Jan; 192(1):40-6. PubMed ID: 26314584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic Body Radiotherapy Treatment for Recurrent, Previously Irradiated Head and Neck Cancer.
    Stanisce L; Koshkareva Y; Xu Q; Patel A; Squillante C; Ahmad N; Rajagopalan K; Kubicek GJ
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818780086. PubMed ID: 29890894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy for recurrent squamous cell carcinoma of the head and neck: results of a phase I dose-escalation trial.
    Heron DE; Ferris RL; Karamouzis M; Andrade RS; Deeb EL; Burton S; Gooding WE; Branstetter BF; Mountz JM; Johnson JT; Argiris A; Grandis JR; Lai SY
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1493-500. PubMed ID: 19464819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.